Table 5.
Survival and 95% confidence intervals in patients with hepatocellular carcinoma, according to age and year of diagnosis, central and northern Denmark 1998–2009
| Year of diagnosis
|
||||
|---|---|---|---|---|
| 1998–2000 | 2001–2003 | 2004–2006 | 2007–2009 | |
| Number of cancer patients | 79 | 103 | 114 | 151 |
| Median age (years) | 67 | 68 | 66 | 69 |
| 1 year | ||||
| Survival | 24% (15%–34%) | 28% (20%–37%) | 22% (15%–30%) | 37% (29%–45%) |
| MRR | 1 (reference) | 0.94 (0.67–1.33) | 1.05 (0.76–1.45) | 0.67 (0.49–0.93) |
| Adjusted MRRa | 1 (reference) | 0.93 (0.66–1.31) | 1.04 (0.75–1.45) | 0.65 (0.47–0.91) |
| 3 year | ||||
| Survival | 5% (2%–11%) | 17% (11%–25%) | 9% (4%–15%) | 12% (7%–19%)b |
| MRR | 1 (reference) | 0.81 (0.59–1.10) | 0.97 (0.72–1.31) | 0.71 (0.53–0.94)b |
| Adjusted MRRa | 1 (reference) | 0.80 (0.59–1.09) | 0.97 (0.72–1.31) | 0.70 (0.52–0.93)b |
| 5 year | ||||
| Survival | 3% (0%–8%) | 7% (3%–13%) | 6% (3%–12%)b | 9% (5%–16%)b |
| MRR | 1 (reference) | 0.84 (0.62–1.14) | 0.96 (0.72–1.29)b | 0.70 (0.53–0.93)b |
| Adjusted MRRa | 1 (reference) | 0.83 (0.61–1.13) | 0.95 (0.71–1.27)b | 0.69 (0.52–0.92)b |
a
Notes: adjusted for age and gender;
b
predicted values.
Abbreviation: MRR, mortality rate ratio.